Coastal Roadways Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:57 pm

Quick Insight

Coastal Roadways Ltd, currently priced at ₹38.8 with a market cap of ₹16.1 Cr., presents an intriguing investment opportunity. With a P/E ratio of 11.2, the stock appears undervalued compared to industry peers. However, the low ROE and ROCE of 6.35% and 9.25% respectively indicate room for improvement in capital efficiency. Furthermore, a high promoter holding of 74.98% provides stability but limited room for external investment. The company's low OPM of 8.61% suggests potential operational challenges that need to be addressed. Despite a healthy ICR of 39.33x, the P/BV ratio of 0.51x indicates a significant discount to book value. Investors should closely monitor operational efficiency and profitability metrics before considering investment in Coastal Roadways Ltd.

Competitors of Coastal Roadways Ltd

All Competitor Stocks of Coastal Roadways Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:28 am

Below is a detailed analysis of the quarterly data for Coastal Roadways Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 10.69 Cr.. The value appears strong and on an upward trend. It has increased from 10.48 Cr. (Dec 2024) to 10.69 Cr., marking an increase of 0.21 Cr..
• For Expenses, as of Mar 2025, the value is 9.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.54 Cr. (Dec 2024) to 9.77 Cr., marking an increase of 0.23 Cr..
• For Operating Profit, as of Mar 2025, the value is 0.92 Cr.. The value appears to be declining and may need further review. It has decreased from 0.94 Cr. (Dec 2024) to 0.92 Cr., marking a decrease of 0.02 Cr..
• For OPM %, as of Mar 2025, the value is 8.61%. The value appears to be declining and may need further review. It has decreased from 8.97% (Dec 2024) to 8.61%, marking a decrease of 0.36%.
• For Other Income, as of Mar 2025, the value is -0.31 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Dec 2024) to -0.31 Cr., marking a decrease of 0.35 Cr..
• For Interest, as of Mar 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.02 Cr..
• For Depreciation, as of Mar 2025, the value is 0.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.33 Cr. (Dec 2024) to 0.37 Cr., marking an increase of 0.04 Cr..
• For Profit before tax, as of Mar 2025, the value is 0.22 Cr.. The value appears to be declining and may need further review. It has decreased from 0.63 Cr. (Dec 2024) to 0.22 Cr., marking a decrease of 0.41 Cr..
• For Tax %, as of Mar 2025, the value is 77.27%. The value appears to be increasing, which may not be favorable. It has increased from 30.16% (Dec 2024) to 77.27%, marking an increase of 47.11%.
• For Net Profit, as of Mar 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.44 Cr. (Dec 2024) to 0.05 Cr., marking a decrease of 0.39 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.12. The value appears to be declining and may need further review. It has decreased from 1.06 (Dec 2024) to 0.12, marking a decrease of 0.94.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:15 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:33 pm

Below is a detailed analysis of the balance sheet data for Coastal Roadways Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 4.15 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.15 Cr..
• For Reserves, as of Mar 2025, the value is 19.25 Cr.. The value appears strong and on an upward trend. It has increased from 17.80 Cr. (Mar 2024) to 19.25 Cr., marking an increase of 1.45 Cr..
• For Borrowings, as of Mar 2025, the value is 0.14 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.34 Cr. (Mar 2024) to 0.14 Cr., marking a decrease of 0.20 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2.93 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.55 Cr. (Mar 2024) to 2.93 Cr., marking an increase of 0.38 Cr..
• For Total Liabilities, as of Mar 2025, the value is 26.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.84 Cr. (Mar 2024) to 26.47 Cr., marking an increase of 1.63 Cr..
• For Fixed Assets, as of Mar 2025, the value is 7.56 Cr.. The value appears to be declining and may need further review. It has decreased from 8.92 Cr. (Mar 2024) to 7.56 Cr., marking a decrease of 1.36 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 6.23 Cr.. The value appears strong and on an upward trend. It has increased from 5.88 Cr. (Mar 2024) to 6.23 Cr., marking an increase of 0.35 Cr..
• For Other Assets, as of Mar 2025, the value is 12.68 Cr.. The value appears strong and on an upward trend. It has increased from 10.04 Cr. (Mar 2024) to 12.68 Cr., marking an increase of 2.64 Cr..
• For Total Assets, as of Mar 2025, the value is 26.47 Cr.. The value appears strong and on an upward trend. It has increased from 24.84 Cr. (Mar 2024) to 26.47 Cr., marking an increase of 1.63 Cr..

Notably, the Reserves (19.25 Cr.) exceed the Borrowings (0.14 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Coastal Roadways Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 5.43 (Mar 24) to 3.50, marking a decrease of 1.93.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 5.43 (Mar 24) to 3.50, marking a decrease of 1.93.
• For Cash EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.49 (Mar 24) to 6.84, marking a decrease of 1.65.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 56.38. It has increased from 49.64 (Mar 24) to 56.38, marking an increase of 6.74.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 56.38. It has increased from 49.64 (Mar 24) to 56.38, marking an increase of 6.74.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 98.80. It has increased from 92.22 (Mar 24) to 98.80, marking an increase of 6.58.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.53. This value is within the healthy range. It has increased from 5.95 (Mar 24) to 8.53, marking an increase of 2.58.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.23. This value is within the healthy range. It has increased from 2.91 (Mar 24) to 5.23, marking an increase of 2.32.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.01. This value is within the healthy range. It has decreased from 5.90 (Mar 24) to 5.01, marking a decrease of 0.89.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.54. This value is within the healthy range. It has decreased from 5.45 (Mar 24) to 3.54, marking a decrease of 1.91.
• For PBDIT Margin (%), as of Mar 25, the value is 8.63. This value is below the healthy minimum of 10. It has increased from 6.44 (Mar 24) to 8.63, marking an increase of 2.19.
• For PBIT Margin (%), as of Mar 25, the value is 5.29. This value is below the healthy minimum of 10. It has increased from 3.15 (Mar 24) to 5.29, marking an increase of 2.14.
• For PBT Margin (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 10. It has decreased from 6.40 (Mar 24) to 5.07, marking a decrease of 1.33.
• For Net Profit Margin (%), as of Mar 25, the value is 3.58. This value is below the healthy minimum of 5. It has decreased from 5.90 (Mar 24) to 3.58, marking a decrease of 2.32.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.28. This value is below the healthy minimum of 15. It has decreased from 10.97 (Mar 24) to 6.28, marking a decrease of 4.69.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.72. This value is below the healthy minimum of 10. It has increased from 5.47 (Mar 24) to 8.72, marking an increase of 3.25.
• For Return On Assets (%), as of Mar 25, the value is 5.55. This value is within the healthy range. It has decreased from 9.71 (Mar 24) to 5.55, marking a decrease of 4.16.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.65. It has decreased from 1.69 (Mar 24) to 1.65, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 7.77. This value exceeds the healthy maximum of 3. It has decreased from 8.10 (Mar 24) to 7.77, marking a decrease of 0.33.
• For Quick Ratio (X), as of Mar 25, the value is 7.77. This value exceeds the healthy maximum of 2. It has decreased from 8.10 (Mar 24) to 7.77, marking a decrease of 0.33.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 39.33. This value is within the healthy range. It has increased from 21.13 (Mar 24) to 39.33, marking an increase of 18.20.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 17.33. This value is within the healthy range. It has increased from 8.73 (Mar 24) to 17.33, marking an increase of 8.60.
• For Enterprise Value (Cr.), as of Mar 25, the value is 7.25. It has decreased from 15.34 (Mar 24) to 7.25, marking a decrease of 8.09.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 24) to 0.17, marking a decrease of 0.23.
• For EV / EBITDA (X), as of Mar 25, the value is 2.05. This value is below the healthy minimum of 5. It has decreased from 6.22 (Mar 24) to 2.05, marking a decrease of 4.17.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.29, marking a decrease of 0.18.
• For Price / BV (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.88 (Mar 24) to 0.51, marking a decrease of 0.37.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.29, marking a decrease of 0.18.
• For EarningsYield, as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness